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Abstract
As Malagasy amphibians are facing an impending extinction crisis from the lethal
skin fungus Batrachochytrium dendrobatidis (Bd), it has become imperative to proactively
mitigate the threat. Bd sporangia develop in the skin of infected amphibians and cause the
skin to thicken, leading to ionic imbalance and eventual heart failure. It has been shown
that certain bacterial species are able to inhibit Bd growth on amphibians by producing
antifungal metabolites. Community-based probiotics are one approach used to combat
chytridomycosis by inoculating an environment with Bd-inhibitory bacteria so that many
amphibian species are treated at once. With this method, it is important to minimize
effects on non-target organisms by selecting anti-Bd bacteria that occur on the amphibians’
skins with the goal of augmenting bacterial abundance. The purpose of this study was to
determine which bacteria from an amphibian community at Ranomafana National Park,
Madagascar, are capable of inhibiting Bd. To identify anti-Bd bacterial isolates, inhibition
assays of each isolate against Bd were conducted. Changes in optical density (492nm) of
isolates’ culture filtrates with Bd were compared to controls. After finding which bacteria
were positive for inhibition, relationships between the anti-Bd bacterial families, genera,
and species and the relative abundances found on each frog species were assessed. Overall,
Bd inhibitory isolates were found on every species. Several bacterial isolates were able to
inhibit Bd as found in previous studies. However, only two isolates of Sphingobacterium
multivorum were identified to inhibit Bd at the species level. Based on this study, I
recommend that more research is conducted with greater sample sizes to identify a possible
probiotic species that is more commonly found than S. multivorum.
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Introduction
Amphibian declines have been documented in almost every corner of the
globe for the past 25 years (Beebee and Griffiths, 2005). In fact, amphibians are
arguably the vertebrates most susceptible to extinction with 32.5% of species
threatened (Kilpatrick et al., 2010). Reasons for this decline include land use
change, contaminants, and climate change (Collins, 2010). Another major cause of
amphibian declines is infectious disease such as chytridiomycosis, which is recently
negatively impacting large numbers of amphibians (Kilpatrick et al., 2010).
Batrachochytrium dendrobatidis (Bd), the causal agent of chytridiomycosis, is
a fungal pathogen greatly affecting amphibian populations by causing large-scale
population declines worldwide. For example, 92.5% of ‘critically endangered’
species are undergoing dramatic declines that could be attributed to Bd (Kilpatrick
et al., 2010). This fungus has been found worldwide except for a few locations such
as some parts of Madagascar (Vrendenburg et al., 2012). Bd is thought to be an
emerging pathogen as it was first identified in 1999 (Longcore et al., 1999).
However, recent genomic studies demonstrate that Bd arose approximately 1,000 to
10,000 years ago (Rosenblum et al., 2013). This evolutionary time period is
sufficient to allow quite variable strains as seen around the world, including one
pathogenic strain, global pandemic lineage (GPL), responsible for amphibian
population decline.
The introduction of a virulent strain to naïve amphibian populations is
controversial as there is no clear answer to its origin in terms of location or host
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species. Some findings support the hypothesis that Bd originated in Africa and was
spread by the host species Xenopus laevis as this frog was traded internationally in
the mid 20th century for use as a pregnancy test (Rosenblum et al., 2010). However,
others hypothesize that the North American bullfrog, Rana catesbeiana, was the
original host based on the high allelic variance of Bd isolates on this host species
(Rosenblum et al., 2010). Based on the rate of virulent Bd spread worldwide, there
is no obvious answer to the question of its origin.
The lifecycle of Bd has two major stages: a swimming zoospore and a fixed
sporangium (Bletz et al., 2013). Bd infects its host by zoospores colonizing the
amphibian’s skin. During Bd’s lifecycle, the zoospores form sporangia in the deeper
layers of keratinized skin (Fisher et al., 2009). The sporangia disrupt the vital ion
transport mechanisms of the amphibian’s skin, causing eventual cardiac arrest
(Campbell et al., 2012). Bd virulence and growth rate are quite variable depending
on the strain or environmental factors such as temperature. Cooler temperatures
are associated with faster Bd zoospore production rates, while warmer
temperatures allow for the sporangium to mature at faster rates (Kilpatrick et al.,
2010).
Some amphibian populations persist with Bd because they can counteract
chytridiomycosis through a variety of defense strategies. First, amphibians are able
to produce antimicrobial peptides that inhibit potentially harmful microorganisms
(Harris et al., 2009). Another line of defense against Bd are commensal bacteria on
the frog’s skin that produce antifungal metabolites. By introducing or increasing
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such probiotic bacteria onto infected frogs (bioaugmentation), the infection rate of
Bd can decrease (Harris et al., 2009; Becker and Harris, 2010).
By implementing probiotic bioaugmentation of anti-Bd bacteria to amphibian
skin, Bd-naïve locations, such as areas of Madagascar, can be proactively protected
against the disease (Bletz et al., 2015). Thus, the purpose of my study is to test
bacteria obtained from Malagasy frogs for Bd inhibition in order to obtain bacterial
strains that can one day be used as probiotics that can protect amphibians of
Madagascar, where there is an estimated 465 endemic amphibian species (Fisher et
al., 2009)
Based on previous research, I expect to find several anti-Bd bacterial isolates.
However, I expect to find a different community of anti-Bd bacterial species on each
frog species due to the different array of anti-microbial peptides produced by each
frog species (Woodhams et al., 2006). These peptides likely control which bacterial
species can live on frog skin. I expect that a limited number of anti-Bd bacterial
species are shared among several frog species based on previous research in North
America (Bell et al., 2013), and these species would be potential community
probiotics.
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Materials and Methods
Sample Collection
Six Malagasy amphibian species from Ranomafana National Park were
studied in this analysis: Blommersia blommersae, Boophis elenae, Boophis guibei,
Gephyromantis tschenki, Guibemantis liber, and Mantidactylus majori. Of these
species, B. elenae and G. tschenki are considered “data deficient” as a conservation
status, with the rest of the species being of “least concern” (AmphibiaWeb, 2015).
Sample sizes at the level of amphibian species were low, with the highest being B.
guibei (n=6 individuals) and the lowest being B. elenae (n=3).
Based on the amount of bacterial samples processed from the Malagasy frogs,
255 bacterial samples were studied. Molly Bletz and Reid Harris collected bacterial
swab samples by collecting frogs at night using a different pair of gloves for each
frog handled. Next, the skin of the ventral side of each frog was swabbed, and the
swab was frozen in glycerol solution until bacterial isolation in the lab.
This strategy of sampling frogs from one location allows for the possibility of
discovering a community-wide probiotic if a consistent anti-Bd isolate is found
among several frog species. For example, if anti-Bd bacteria species 1 and 2 are
primarily associated with frog species A, anti-Bd bacteria species 1 and 3 with frog
species B, and anti-Bd bacteria species 1 and 4 with frog species C, then bacteria
species 1 would be a good candidate for a community-based probiotic as it is found
across multiple frog species, thus reducing potential secondary effects such as
creating major differences in bacterial community of some frog species. This
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probiotic could be inoculated to amphibians by introducing the bacteria to an
environmental source, such as a pond, so that many amphibians can be
bioaugmented in a relatively short amount of time (Muletz et al., 2012; Bletz et al.,
2013). Studying the relationships between species of amphibians and anti-Bd
bacterial isolates will be an important factor of this method of experimentation.
Inhibition Assay Preparation
An inhibition assay is a method of finding anti-Bd bacteria by challenging Bd
zoospore growth while in the presence of the bacterium’s metabolites and comparing
Bd growth to several controls that are described below. One percent tryptone broth
cultures of each bacterium were made from the original bacterial isolate plates from
the frog skin swabs and were allowed to grow in the presence of Bd, so as the
bacterium was more likely to produce anti-Bd metabolites, if capable. To
standardize the amount of bacteria used in each inhibition assay, cultures of all
bacterial species will be assayed after three days of growth.
Bd was prepared for use in inhibition assays by using strain JEL in 1%
tryptone broth culture. New plates were prepared by pipetting 1mL of Bd liquid
culture onto 1% tryptone plates and swirling to ensure the plate was covered evenly
and then incubating the plates for 3 days at 21°C. The controls and Bd used to
grow with the bacteria were also be prepared as liquid cultures and incubated at
21°C with agitation for 3 days in preparation for the inhibition assays.
Bd for inhibition assays was obtained by flooding the Bd plates with 5mL of
tryptone and allowing them to sit for 10 minutes with periodic agitation. The liquid
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was removed and filtered through an autoclaved coffee filter into a new falcon tube.
Zoospores passed through the filter and were counted twice using a
haemocytometer, and this average initial concentration was used to create the final
Bd concentration of 2x106 zoospores in 15mL of tryptone solution. To prepare the
heat killed Bd for the “heat-killed” control, 500µL of quantified Bd was put into a
1.5mL microcentrifuge tube and heated at 60°C for 60 minutes. The bacterial and
Bd solutions were places into new 1.5mL microcentrifuge tubes and centrifuged at
10,000 rpm for five minutes to create bacterial cell free supernatants (CFSs) or Bd
cell free supernatants, which were controls grown without the presence of bacteria.
Using a needle attached to a 3mL syringe, I collected 1mL of supernatant. The
supernatant was then filtered through a 0.22µm syringe filter into a sterile
microtube to ensure supernatants were cell-free. This experimental design is based
on Bell et al. (2013).
Inhibition Assay Experimental Design
The experimental samples included 50µL of Bd zoospore solution and 50µL of
bacterial CFS. A nutrient depleted control samples had 50µL of Bd zoospore
solution and 50µL of sterile water (Figure 1). The nutrient depleted control served
as the basis of comparison of growth for Bd as it controls for differing levels of
tryptone nutrients after depletion by bacterial in broth culture. This nutrient
depleted control is important since the Bd zoospores that were added to the 96 wells
in the inhibition assay were in wells that were nutrient depleted by bacterial
growth to various extents depending on how much each bacterial strain grew while
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in pure culture. Bd and bacteria use the same nutrients to some degree, so it is
important to distinguish between the effects of nutrient depletion and the effects of
anti-Bd metabolites secreted by bacteria on Bd growth. The positive control
contained 50 µL of Bd zoospore solution with 50µL of Bd CFS to show growth
attributed to Bd zoospores alone (Figure 1). The positive control shows growth of
Bd zoospores without the effects of bacterial presence. The heat-killed Bd controls
contained 50µL of heat-killed Bd zoospores, as described above, and 50µL of Bd CFS
(Figure 1). This control was a measure of total mortality of Bd. Finally, the
negative control contained 50µL of 1% tryptone medium and 50µL of positive
extract (Figure 1). The negative control focused on possible contamination
presence, as no growth should be seen from the lack of Bd zoospores.

Test Samples
50µL Bd zoospores
50µL bacterial extract

	
  	
  

Nutrient Depleted
50µL Bd zoospores
50µL sterile water

Heat-Killed Control
50µL heat-killed Bd
zoospores
50µL Bd extract

Positive Control
50µL Bd zoospores
50µL Bd extract

Negative Control
50µL 1% tryptone
medium
50µL Bd extract

Figure 1. Inhibition assay set up for each control and test samples that will be in 96
well plates.
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The optical density (OD at 492 nm) of all samples was determined on days 0,
4, 7, and 10 after the start of the inhibition assay. OD is a measure of Bd growth,
as samples with larger Bd population densities will have higher OD readings.
Samples were incubated at 21°C. during this time. Each sample had 3 replicates,
and growth curves were created for each isolate’s average rate of growth and
compared to the nutrient depleted control. As mentioned above, the nutrient
depleted control samples were used as a benchmark to determine which isolates had
anti-Bd properties.
Genetic Analysis
The final analysis of this experiment is to analyze the relationships between
species of amphibians and families of bacteria by completing polymerase chain
reactions (PCR) in order to sequence a portion of the 16S rRNA gene of the anti-Bd
bacterial isolates. These sequences are used as a way to identify each strain by
comparing each isolate’s sequence to the NCBI BLAST database.
Statistical Analysis
A bacterial isolate was classified as Bd-inhibiting if the mean proportion of
inhibition of growth for the three replicates, compared to the nutrient depleted
control, was greater than or equal to 0.85. This threshold was assigned in order to
be consistent with Molly Bletz’s larger data set analysis. By comparing inhibition
to the nutrient depleted control’s growth, the inhibition proportion accounts for
varying amounts of tryptone nutrients being depleted by either bacterial isolates or
Bd zoospores. Due to small sample sizes, several nonparametric statistical tests
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were used. Wilcoxon rank sum test was used to compare values of inhibition, and
Fisher’s exact test was used to compare proportions of inhibitory isolates compared
to all isolates found. Standard boxplots formed from the 25th, 50th, and 75th
quartiles, along with tails created by adding and subtracting the interquartile range
multiplied by 1.5, were constructed to depict variation in inhibition among the
samples. ANOVA was used to compare average inhibition scores between bacterial
families and genera.
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Results
Amphibian Level
Inhibition of Bd was estimated by calculating the median inhibition score
across all of the bacterial strains on all individuals for each amphibian species.
This value was around 0.6 with low variability. The Wilcoxon rank sum test
indicated that only the B. blommersae and G. liber species pair differed in inhibition
values (W=1296; p = 0.006) (Figure 2).
Median inhibition values were calculated for each individual frog within a
species with boxplots depicting the variation in values for each frog (Figure 3). For
B. blommersae, a significant difference was found between J4-010 and J4-013
(W=20, p-value=0.025), J4-011 and J4-013 (W=6, p-value=0.029), J4-012 and J4-013
(W=4, p-value=0.005), and J4-013 and J4-040 (W=76, p-value=0.046) using
Wilcoxon rank sum test (Figure 3). For B. guibei, the only statistical difference in
median inhibition values was between J4-021 and J4-024 (W=40, p-value=0.036)
(Figure 3). For G. liber, the only statistical difference in inhibition values was
between J4-030 and J4-032 (W=91, p-value=0.047) (Figure 3). There were no
statistical differences in inhibition values for B. elenae, G. tschenki, and M. majori
(Figure 3). To understand how many inhibitory isolates were found on each species
that made up the inhibition scores, proportions of inhibitory isolates to total isolates
were calculated.
When comparing the proportion of inhibitory isolates found across amphibian
species, a different pattern is seen. There is no statistically significant difference
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between species using pair-wise Fisher’s exact test with all p-values greater than
0.05 (Figure 4). In all species every individual frog had at least one inhibitory
isolate with the exception of G. tschenki and M. majori, which had two out of four
frogs and two out of six frogs without at least one inhibitory isolate, respectively
(Figure 4).
Across individual frogs, there was variation among proportions of inhibitory
isolates (Figure 5). However, the level of variation changes among species (Figure
5). Of all six frog species, only two species exhibited a statistically significant
difference in proportion of inhibitory isolates among individuals. Only J4-010 and
J4-012 of B. blommersae and A3-032 and A3-034 of M. majori showed a difference in
proportion of inhibitory isolates within their respective species using Fisher’s exact
test with p-value of 0.0498 and 0.0455, respectively (Figure 5). Low sample sizes of
frogs within each species may have contributed to the lack of significant differences
in proportion of inhibitory isolates. Overall, inhibitory isolates made up the
minority of the isolates found in cutaneous cultures from each frog, except for two
frogs, as they had less than 50% inhibitory isolates (Figure 5).
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1.0
0.5
0.0

Median Inhibition

B. blommersae

B. elenae

B. guibei

G. tschenki

G. liber

M. majori

Frog Species

Figure 2. Median inhibition for each frog species. Each boxplot represents the
median of inhibition across all frogs sampled of each species in addition to 25%, 75%
quartiles and outliers. Species are arranged by alphabetical order. A high
inhibition represents a better ability of inhibiting Bd growth. The only statistical
difference in inhibition values is between B. blommersae and G. liber using
Wilcoxon rank sum test.

	
  
	
  

17	
  

B	
  

Boophis elenae
Median Inhibition

0.6
0.2
-0.2

Median Inhibition

1.0

Blommersia blommersae

0.0 0.2 0.4 0.6 0.8 1.0

A
.	
  

J4-033

J4-010 J4-011 J4-012 J4-013 J4-040

D	
  

Gephyromantis tschenki

0.7
0.5

Median Inhibition

0.3

-0.4

0.0

0.4

Median Inhibition

0.8

0.9

Boophis guibei

A3-001

J4-019 J4-020 J4-021 J4-022 J4-023 J4-024

A3-068

J2-027

J2-034

Individual Frog

Individual Frog

E	
  

F	
  
Guibemantis liber

Mantidactylus majori
0.8
0.6
0.4
0.0

0.2

Median Inhibition

1.0

1.0
0.6
0.2
-0.2

Median Inhibition

J4-035

Individual Frog

Individual Frog

C	
  

J4-034

J4-029

J4-030

J4-031

J4-032

A3-022 A3-032 A3-033 A3-034 A3-035 A3-041

Individual Frog

Individual Frog

Figure 3 Median inhibitions for each individual frog. Each boxplot represents the
median of inhibition across all frogs sampled of each species. A high inhibition
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represents a better ability of inhibiting Bd growth. Statistical differences in
inhibition values between B. blommersae frogs, graph A, using Wilcoxon rank sum
test are between J4-010 and J4-013, J4-011 and J4-013, J4-012 and J4-013, and J4013 and J4-040. For B. guibei, graph C, the only statistical difference in inhibition
values is between J4-021 and J4-024. For G. liber, graph E, the only statistical
difference in inhibition values is between J4-030 and J4-032. There are no
statistical differences in inhibition values for B. elenae (graph B), G. tschenki (graph
D), and M. majori (graph F).

Propportion of Inhibitory Isolates

1	
  

0.8	
  

0.6	
  

0.4	
  

0.2	
  

0	
  
B. blommersae

B. elenae

B. guibei

G. tschenki

G. liber

M. majori

Frog Species

Figure 4. Proportion of inhibitory isolates by frog species. Each bar represents the
proportion of inhibitory isolates compared to total number of isolates found on each
frog species. The error bars represent the 95% confidence interval. No statistically
significant difference between any species was seen using Fisher’s exact test.
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0.2	
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Individual Frog
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Proportion of Inhibitory
Isolates

D	
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0.4
0.2
0

Individual Frog

Guibemantis liber

Boophis elenae
1	
  
0.8	
  
0.6	
  

F	
  

1

0.4	
  
0.2	
  
0	
  
J4-033

0.8
0.6
0.4
0.2
0
J4-029 J4-030 J4-031 J4-032
Individual Frog

J4-034

J4-035

Individual Frog

Gephryomantis tschenki
Proportion of Inhibitory
Isolates

Proportion of Inhibitory
Isolates

Boophis guibei

E	
  

B	
  
Proportion of Inhibitory
Isolates

Proportion of Inhibitory
Isolates

Blommersia blommersae

1
0.8
0.6
0.4
0.2
0
A3-001 A3-068 J2-027 J2-034
Individual Frog

Mantidactylus majori
Proportion of Inhibitory
Isolates

A
.	
  

1
0.8
0.6
0.4
0.2
0

Individual Frog

Figure 5. Proportion of inhibitory isolates by individual frog. Each bar represents
the proportion of inhibitory isolates compared to the total number of isolates found
on each individual frog. For B. blommersae, graph A, the only statistically different
proportions are between J4-010 and J4-012 using Fisher’s exact test. For M.
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majori, graph F, the only statistically significant different proportions are between
A3-032 and A3-034 using Fisher’s exact test. For B. elenae, B. guibei, G. tschenki,
and G. liber, graphs B, C, D, and E respectively, there are no statistically significant
differences between proportions of inhibitory isolates using Fisher’s exact test.
Bacterial Level
Average inhibition scores were calculated for each identified bacterial family,
genus, and species to identify groups of anti-Bd bacteria to help guide options for a
community probiotic. Of the families identified, three had average inhibition scores
over the threshold of 0.85 when comparing more than one isolate, noted by a § in
Figure 7. I have also identified the five most commonly identified bacterial families,
those with the five highest relative abundances across amphibian species, noted by
an * (Figure 6, Figure 7). Xanthomonadaceae, Caulobacteraceae, and
Sphingobacteriaceae were identified as families having an average inhibition score
above 0.85, and their relative abundances were 4.7%, 4.0%, and 2.5% respectively
(Figure 7). The five most commonly found bacterial families, in order, are
Microbacteriaceae (26.9%), Micrococcaceae (11.3%), Brevibacteriaceae (9.8%),
Streptomycetaceae (5.7%), and Xanthomonadaceae (4.7%) (Figure 6, Figure 7). Of
these families, only Xanthomonadaceae had an average inhibition over 0.85 (Figure
7). These families differed in average inhibition scores (F= 6.67, df=6, 139, pvalue=3.21E-6).
Of the genera identified, two had average inhibition scores over the threshold
of 0.85 when comparing more than one isolate, noted by a § (Figure 9). I have also
identified the five most commonly identified bacteria, those with the five highest
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relative abundances across amphibian species, noted by an * (Figure 8, Figure 9).
Sphingobacterium (from the Sphingobacteriaceae family) and Stenotrophomonas
(from the Xanthomonadaceae family) were identified as genera having an average
inhibition score above 0.85, and their relative abundances were 1.6% and 2.4%
respectively (Figure 9). The five most commonly found bacterial genera, in order,
are Microbacterium (16.8%), Brevibacterium (9.8%), Kocuria (8.5%), Sphingomonas
(3.9%), and Curtobacterium (2.9%) (Figure 8, Figure 9). Of these genera, none had
an average inhibition over 0.85 (Figure 9). These genera differed in average
inhibition scores (F= 3.80, df=6,97, p-value=0.002).
Of the species identified, one had an average inhibition score over the
threshold of 0.85 when comparing more than one isolate, noted by a § (Figure 10). I
have also identified the five most commonly found bacterial species, those with the
five highest relative abundances across amphibian species, noted by an * (Figure
10). Sphingobacterium multivorum was identified as a bacterial species having an
average inhibition score above 0.85 and had a relative abundance of 0.78% (Figure
10). The five most commonly identified bacterial species, in order, are
Brevibacterium aureum (7.1%), Microbacterium chocolatum (3.9%), Kocuria
palustris (2.4%), Acinetobacter rhizospaerae (1.2%), and Luteibacter rhizovicinus
(1.2%), as seen in Figure 10. Of these species, none had an average inhibition over
0.85 (Figure 10). The species did not differ in inhibition scores (F= 2.06, df=5, pvalue=0.09) probably due to large standard error bars for some species and low
sample size in others.
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G. tschenki

M. majori

G. liber

B. elenae

B. guibei

B. blommersae

Figure 6. Bacterial community structure on the skins of six amphibian species.
Bacteria were identified to the family level.
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Figure 7. Average inhibition for each bacterial family identified. Each bar
represents the average inhibition for a bacterial family. Depicted families represent
the five most commonly found families (noted with *) and families with an average
inhibition greater than 0.85 with more than one isolate (noted with §). Relative
abundance of each family decreases from left to right. Error bars represent
standard error for each family. Families were statistically different using ANOVA.
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M. majori

G. liber

B. elenae

25	
  

B. guibei

B. blommersae

Figure 8. Bacterial community structure on the skins of six amphibian species.
Bacteria were identified to the genus level.
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Figure 9. Average inhibition for each bacterial genus identified. Each bar
represents the average inhibition for a bacterial genus. Depicted genera represent
the five most commonly found genera (noted with *) and genera with an average
inhibition greater than 0.85 with more than one isolate (noted with §). Relative
abundance of each genus decreases from left to right. Error bars represent
standard error for each genus. Genera were statistically different using ANOVA.
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Figure 10. Average inhibition for each bacterial species identified. Each bar
represents the average inhibition for a bacterial species. Depicted species represent
the five most commonly found species (noted with *) and species with an average
inhibition greater than 0.85 with more than one isolate (noted with §). Relative
abundance of each species decreases from left to right. Error bars represent
standard error for each species. Species were not statistically different using
ANOVA.
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Discussion
With this study, I tested for relationships between amphibian and bacterial
species within the same community. Using the community probiotic approach, a Bd
inhibitory bacterial species found commonly among amphibian species would be a
great candidate for future approaches to amphibian protection (Bletz, 2013). Such a
wide distribution would reduce the chances of non-target effects of bacterial
introduction to the environment since many of the amphibian species already have
the isolate as a member of its normal microbiota (Bletz, 2013). Part of the selection
process is to analyze the current inhibition abilities of isolates for each frog species
found at the site while studying variation across individual frogs within a species.
The overall median degree of inhibition across species was relatively constant
and lower than 0.85, which means based on microbial protection alone that at least
half of the individuals are at risk of Bd infection. However, as yet it is not known
how the 0.85 threshold relates to individual frog survival when infected with Bd.
However, this result shows that all species studied should be targeted for probiotic
protection to the same degree. Each species also had inhibitory bacterial species
making up the minority of total isolates since all proportions of inhibitory isolates
were below 0.5 (Figure 4). However, each species studied had at least one
inhibitory isolate found in its normal microbiota (Figure 4). When studying the
proportion of inhibitory isolates on the individual frogs, there is not much variation
between frogs of the same species (Figure 5).
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For bacteria, only a few families, genera, and one species could be identified
as inhibitory of Bd. Only Xanthomonadaceae was identified as a bacterial family
whose average inhibition scores of its isolates exceeded the 0.85 threshold, while
also being commonly found on the frogs, one of the five highest relative abundances
across amphibian species (Figure 7). In fact, this family was found on all six species
of frogs studied (Figure 6). No genera were identified as being both one of the most
commonly found genera, those with the five highest relative abundances across
amphibian species, and having an average inhibition score over 0.85. However, the
inhibitory genus Sphingobacterium was found on three of the six frog species, G.
tschenki, G. liber, and B. elenae, and the genus Stenotrophomonas was found on four
of the six frog species, G. tschenki, M. majori, B. elenae, and B. guibei (Figure 8).
Only one bacterial species, S. multivorum, was identified as having an average
inhibition score over 0.85. This species only had two isolates, out of 255 isolates in
the study, based on culture-dependent genetic analysis. Although this was the only
species that met the 0.85 threshold of average inhibition scores, other species
identified did meet this qualification but only one isolate was identified. Because of
low relative abundance of the inhibitory isolate S. multivorum, I cannot recommend
it as a future probiotic focused on the species studied until culture independent
abundance can confirm its spread across the amphibian species studied. Using
culture media to encourage S. multivorum growth, rather than 1% tryptone, in the
future may also give a more accurate relative abundance that is found on the
amphibians. As S. multivorum was the only bacterial species found that was
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inhibitory, I cannot recommend other possible probiotics on the species level based
on the outcomes of this study.
Variation among some isolates of the same bacterial species (i.e. A.
rhizospaerae) contributed to a high p-value for the ANOVA test, but does indicate
different strains of the species with widely varying Bd inhibition abilities. Such
variation in inhibition traits for some species could harm community probiotic
approaches as high variation within certain bacterial species may indicate a high
mutation rate. When depending on a probiotic approach to defend against Bd, such
high mutation rates may hinder defense against Bd, or may even help the fungus to
grow in some cases. As such, researchers should understand the bacterium of
choice in detail, such as the variation in inhibition between strains of the species,
before adding it to the community in case of future issues.
The vulnerability level of the amphibian species studied was “least concern”,
or “data deficient”, suggesting that they have a large population size with large
genetic diversity (AmphibiaWeb, 2015). Such diversity in genetics could lead in a
diversity of antimicrobial peptides produced by the host amphibians. As such,
cutaneous microbiota should be diverse within species to reflect the diversity of
antimicrobial peptides produced as a result of genetic variation among the species.
In addition to antimicrobial peptides, amphibian habitat and life history could also
contribute to the diversity in skin microbiota. However, more work in the field of
diversity needs to be conducted so that researchers can use probiotics in a safe
manner. Such future work could include assaying different species genetic
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diversity, studying antimicrobial peptide diversity and its effects on bacterial Bd
inhibition, and microbial diversity in relation to habitat and life history in general.
By identifying certain bacterial families, genera, and species that are capable of Bd
inhibition this study serves as a stepping stone for researchers to find a probiotic
that is suitable for the Ranomafana area of Madagascar while also cautioning the
amount of variation possible for inhibition within bacterial species

	
  
	
  

32	
  

References
AmphibiaWeb: Information on amphibian biology and conservation. [web
application]. 2015. Berkeley, California: AmphibiaWeb.
Available: http://amphibiaweb.org/. (Accessed: Feb 16, 2015).
Becker, M. H., & Harris, R. N. (2010). Cutaneous bacteria of the redback
salamander prevent morbidity associated with a lethal disease. Plos One, 5(6),
e10957.
Bell, S., Alford, R., Garland, S., Padilla, G., & Thomas, A. (2013). Screening
bacterial metabolites for inhibitory effects against Batrachochytrium
dendrobatidis using a spectrophotometric assay. Diseases of Aquatic
Organisms, 103(1), 77-85. Retrieved March 18, 2015, from PubMed.
Beebee, T. J. C., & Griffiths, R. A. (2005). The amphibian decline crisis: A
watershed for conservation biology?. Biological Conservation, 125(3), 271.
Bletz, M. C., Rosa, G. M., Andreone, F., Courtois, E. A., Schmeller, D. S., Rabibisoa,
N. H., ... & Crottini, A. (2015). Widespread presence of the pathogenic fungus
Batrachochytrium dendrobatidis in wild amphibian communities in
Madagascar. Scientific reports, 5.
Bletz, M. C., Loudon, A. H., Becker, M. H., Bell, S. C., Woodhams, D. C., Minbiole,
K. P. C., et al. (2013). Mitigating amphibian chytridiomycosis with
bioaugmentation: Characteristics of effective probiotics and strategies for their
selection and use. Ecology Letters, 16(6), 807.
Campbell, C. R., Voyles, J., Cook, D. I., & Dinudom, A. (2012). Frog skin epithelium:
Electrolyte transport and chytridiomycosis. International Journal of
Biochemistry and Cell Biology, 44(3), 431.
Collins, J. P. (2010). Amphibian decline and extinction: What we know and what we
need to learn. Diseases of Aquatic Organisms, 92(2-3), 93. doi:10.3354/dao02307
Fisher, M. C., Garner, T. W. J., & Walker, S. F. (2009). Global emergence of
batrachochtrium dendrobatidis and amphibian chytridiomycosis in space, time,
and host. Annual Review of Microbiology, 63, 291.
Harris, R. N., Brucker, R. M., Walke, J. B., Becker, M. H., Schwantes, C. R.,
Flaherty, D. C., et al. (2009). Skin microbes on frogs prevent morbidity and
mortality caused by a lethal skin fungus. The International Society of Microbial
Ecology Journal, 3, 818.
	
  
	
  

33	
  

Kilpatrick, A. M., Briggs, C. J., & Daszak, P. (2010). The ecology and impact of
chytridiomycosis: An emerging disease of amphibians. Trends in Ecology &
Evolution, 25(2), 109.
Longcore, J.E., Pessier, A.P. & Nichols, D.K. (1999). Batrachochytrium
dendrobatidis gen. et sp. nov., a chytrid pathogenic to amphibians. Mycologia,
91, 219–227.
Muletz, C. R., Myers, J. M., Domangue, R. J., Herrick, J. B., & Harris, R. N. (2012).
Soil bioaugmentation with amphibian cutaneous bacteria protects amphibian
hosts from infection by batrachochytrium dendrobatidis. Biological
Conservation, 152, 119.
Rosenblum, E. B., James, T. Y., Zamudio, K. R., Poorten, T. J., Ilut, D., Rodriguez,
D., et al. (2013). Complex history of the amphibian-killing chytrid fungus
revealed with genome resequencing data. Proceedings of the National Academy
of Sciences of the United States of America, 110(23), 9385.
Rosenblum, E. B., Voyles, J., Poorten, T. J., & Stajich, J. E. (2010). The deadly
chytrid fungus: A story of an emerging pathogen. PLOS Pathogens, 6(1)
Vredenburg, V.T., du Preez, L., Raharivololoniaina, L., Vieites, D.R., Vences, M. &
Weldon, C. (2012). A molecular survey across Madagascar does not yield
positive records of the amphibian chytrid fungus Batrachochytrium
dendrobatidis. Herpetol. Notes, 5, 507–517.
Woodhams, D. C., Rollins-Smith, L. A., & Carey, C. (2006). Population trends
associated with skin peptide defenses against chytridiomycosis in Australian
frogs. Oecologia, 146(4), 531-540.

	
  
	
  

34	
  

